BabySure**

The Babysure newborn screening test, conducted at the Diag Medical System, is a vital procedure in infant healthcare. By collecting a small amount of blood from the baby's heel within 24-72 hours after birth, this test enables early detection of potential genetic and metabolic disorders, including congenital hypothyroidism, G6PD deficiency, congenital adrenal hyperplasia, and amino acid disorders. Timely medical intervention based on the test results can ensure the optimal physical and intellectual development of the child. The blood collection process is performed by experienced medical staff, strictly adhering to sterile procedures and using specialized kits, ensuring absolute safety for newborns. The blood sample is then analyzed at Diag's modern laboratory, where advanced technologies and strict quality control processes are applied, ensuring high accuracy and reliability of the results.